Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
141 hedge funds and large institutions have $580M invested in Flexion Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 20 closing their positions.
30% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 20
13% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 40
12% more capital invested
Capital invested by funds: $517M → $580M (+$62.6M)
4% more funds holding
Funds holding: 135 → 141 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
54% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $3.33M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$7.25M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$6.05M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$5.82M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.01M |
| 5 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$2.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$12.5M |
| 2 |
CC
Clearline Capital
New York
|
-$4.16M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.95M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.17M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.84M |
FLXN Hedge Fund Activity: Q4 2020 in Review
141 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q4 2020, worth a combined $580M — up 12% from $517M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new FLXN positions and 20 closed out — a net gain of 6 holders — while 45 added to existing stakes and 40 trimmed.
The largest buyer was OrbiMed, adding an estimated $7.25M. The largest seller was Miller Value Partners, cutting an estimated $12.5M.
- 141 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q4 2020, up from 135 in Q3 2020.
- Funds reported $580M of Flexion Therapeutics, Inc. stock for Q4 2020, up 12% quarter-over-quarter.
- 26 funds opened new Flexion Therapeutics, Inc. positions in Q4 2020 and 20 closed out, a net change of +6 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q4 2020 was OrbiMed, an estimated $7.25M added.
- The largest Flexion Therapeutics, Inc. seller in Q4 2020 was Miller Value Partners, an estimated $12.5M sold.
Based on aggregated 13F filings for Q4 2020.